Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Effects of Very Early Use of Rosuvastatin in Preventing Recurrence of Ischemic Stroke (EUREKA)

This study has been terminated.
(Slow enrollment)
Information provided by (Responsible Party):
Ji Hoe Heo, Severance Hospital Identifier:
First received: May 26, 2011
Last updated: November 19, 2014
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2013
  Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)